20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T40997 | GLP-1R modulator C16 | GLP-1R modulator C16 | Glucagon Receptor |
GLP-1R modulator C16 is a variable modulator that significantly increases the binding affinity of GLP-4. | |||
T40279 | GLP-1R modulator L7-028 | GLP-1R modulator L7-028 | cAMP , Glucagon Receptor |
GLP-1R modulator L7-028 is a variant modulator that enhances affinity for GLP-1 and cAMP signaling. | |||
T11409 | GLP-26 | HBV | |
GLP-26 disrupts the encapsidation of pre-genomic RNA, causes nucleocapsid disassembly and reduces cccDNA pools. GLP-26 is a HBV capsid assembly modulators (CAM), inhibits HBV DNA replication in Hep AD38 system (IC50=3 nM... | |||
T3984 | GLP-1(7-36), amide | MKC 253,Human GLP-1-(7-36)-amide,Glucagon-like Peptide 1 (7-36) amide,Glucagon-Like Peptide (GLP) I (7-36), amide, human,GLP-1(7-36),GLP-1-(7-36)-amide | Glucagon Receptor |
GLP-1(7-36), amide (MKC 253) is a peptide hormone released from intestinal L-cells upon nutrient consumption. It binds the GLP-1 receptor in the pancreas and displays various antidiabetic effects by potentiating glucose-... | |||
T37890L | GLP-1(28-36)amide acetate | GLP-1(28-36)amide acetate(1225021-13-5 Free base) | Antioxidant , Glucagon Receptor |
GLP-1(28-36)amide acetate inhibits mitochondrial permeability transition with antioxidant, anti-diabetic and cardioprotection activities. | |||
TP1376 | GLP-1(7-37) acetate(106612-94-6 free base) | GLP-1(7-37) acetate | Others , Glucagon Receptor |
Glp-1(7-37) acetate is an intestinal insulin hormone that enhances glucose-induced insulin secretion. | |||
T9579L | GLP-1 receptor agonist 9 citrate | GLP-1 receptor agonist 9 citrate (2401892-71-3 Free base) | Glucagon Receptor |
GLP-1 receptor agonist 9 citrate is an agonist of GLP-1. | |||
T37891L | GLP-1(32-36)amide acetate | GLP-1(32-36)amide acetate(1417302-71-6 Free base) | Others |
GLP-1(32-36)amide acetate is a pentapeptide and derived from the C terminus of the glucoregulatory hormone GLP-1. GLP-1(32-36)amide acetate could inhibit weight gain and modulate whole body glucose metabolism in diabetic... | |||
T15387 | GLP-1R Antagonist 1 | Glucagon Receptor | |
GLP-1R Antagonist 1 is an orally active, CNS penetrant and non-competitive glucagon-like peptide 1 receptor (GLP-1R) antagonist (IC50: 650 nM). | |||
TP2252 | GLP-1 (9-36) amide | Glucagon Receptor | |
antagonist at the human GLP-1 receptor | |||
T36579 | GLP-1R Agonist DMB | Glucagon Receptor | |
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor). | |||
T9579 | GLP-1 receptor agonist 9 | Glucagon Receptor | |
1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist. | |||
T63909 | GLP-1R agonist 3 | Glucagon Receptor | |
GLP-1R agonist 3 is a thickened imidazole derivative compound that is a potent agonist of GLP-1R. GLP-1R agonist 3 has shown research potential in diabetes. | |||
T61483 | GLP-1R modulator C5 | Glucagon Receptor | |
GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes. | |||
TP2253 | GLP-2(rat) | GLP-2 (rat) | Others |
intestinal epithelium-specific growth factor | |||
T11408 | Orforglipron | LY3502970,GLP-1 receptor agonist 1 | Glucagon Receptor |
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults. | |||
TP1141 | GLP-1(7-36), amide acetate | GLP-1(7-36) Acetate,Human GLP-1-(7-36)-amide Acetate | |
GLP-1(7-36) Acetate is a major intestinal hormone that stimulates glucose-induced insulin secretion from β cells. | |||
TP1157 | GLP-2(1-33)(human) | GLP-2 (human),Glucagon-like peptide 2 (human) | |
GLP-2(1-33) (human) is an enteroendocrine hormone which stimulates the growth of the intestinal epithelium. | |||
T37891 | GLP-1(32-36)amide | ||
GLP-1(32-36)amide is a pentapeptide compound derived from the C terminus of the glucoregulatory hormone GLP-1. This compound has shown potential in inhibiting weight gain and regulating glucose metabolism in diabetic mic... | |||
T37890 | GLP-1(28-36)amide | ||
GLP-1(28-36)amide, a C-terminal nonapeptide derived from the cleavage of GLP-1 by neutral endopeptidase (NEP), is a significant product. It functions as an antioxidant and primarily targets the mitochondrion, where it ef... |